# A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers

> **NCT02265718** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 97 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ritalin
- **DRUG:** Placebo
- **DRUG:** Ritalin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02265718
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2019-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02265718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02265718, "A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02265718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*